Detalhe da pesquisa
1.
Universal Prenatal Screening and Testing and Chlamydia trachomatis Conjunctivitis in Infants.
Sex Transm Dis
; 48(9): e122-e123, 2021 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33346588
2.
Infective dermatitis associated with HTLV-1 infection in a girl from Trinidad: Case report and review of literature.
Pediatr Dermatol
; 36(1): e12-e16, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30338553
3.
Diagnostic Practices for Suspected Community-Acquired Central Nervous System Infection in the Post-Conjugate Vaccine Era.
Pediatr Emerg Care
; 35(11): 774-776, 2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28463942
4.
IgE anti-Haemophilus influenzae type b (Hib) antibodies detected in serum of Hib-vaccinated asthmatic and non-asthmatic pediatric patients.
Minerva Pediatr
; 70(2): 111-116, 2018 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-27187042
5.
Seroprevalence of Chlamydia trachomatis in Inner-City Children and Adolescents-Implications for Vaccine Development.
Sex Transm Dis
; 44(12): 717-721, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-28876302
6.
Predicted serotype-specific effectiveness of pneumococcal conjugate vaccines V114 and PCV20 against invasive pneumococcal disease in children.
Expert Rev Vaccines
; 23(1): 60-68, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38073483
7.
Potential serotype-specific effectiveness against IPD of pneumococcal conjugate vaccines V114 and PCV20 in children given a 2+1 dosing regimen.
Expert Rev Vaccines
; 23(1): 467-473, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38546743
8.
Immunogenicity of Current and Next-Generation Pneumococcal Conjugate Vaccines in Children: Current Challenges and Upcoming Opportunities.
Open Forum Infect Dis
; 11(5): ofae220, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38770212
9.
PCV15, a pneumococcal conjugate vaccine, for the prevention of invasive pneumococcal disease in infants and children.
Expert Rev Vaccines
; 23(1): 137-147, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38111990
10.
A phase 3, single-arm, open-label study to evaluate the safety, tolerability, and immunogenicity of a 15-valent pneumococcal conjugate vaccine, V114, in a 3+1 regimen in healthy infants in South Korea (PNEU-PED-KOR).
Hum Vaccin Immunother
; 20(1): 2321035, 2024 Dec 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-38497448
11.
Pneumococcal Vaccine Breakthrough and Failure in Infants and Children: A Narrative Review.
Vaccines (Basel)
; 11(12)2023 Nov 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38140155
12.
An indirect treatment comparison (ITC) and matching-adjusted indirect comparison (MAIC) between a 15-valent (V114) and a 20-valent (PCV20) pneumococcal conjugate vaccine among healthy infants.
Expert Rev Vaccines
; 22(1): 906-917, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37846456
13.
The 15-valent pneumococcal conjugate vaccine V114 induces cross-reactive antibodies against pneumococcal serotype 6C.
Hum Vaccin Immunother
; 19(2): 2235238, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37529944
14.
A phase 3, multicenter, randomized, double-blind, active-comparator-controlled study to evaluate the safety, tolerability, and immunogenicity of a 4-dose regimen of V114, a 15-valent pneumococcal conjugate vaccine, in healthy infants (PNEU-PED).
Vaccine
; 41(5): 1142-1152, 2023 01 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36621410
15.
A phase 3, multicenter, randomized, double-blind study to evaluate the interchangeability of V114, a 15-valent pneumococcal conjugate vaccine, and PCV13 with respect to safety, tolerability, and immunogenicity in healthy infants (PNEU-DIRECTION).
Vaccine
; 41(3): 657-665, 2023 01 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36522265
16.
Safety, tolerability, and immunogenicity of V114 pneumococcal vaccine compared with PCV13 in a 2+1 regimen in healthy infants: A phase III study (PNEU-PED-EU-2).
Vaccine
; 41(15): 2456-2465, 2023 04 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36841723
17.
Safety and Immunogenicity of V114 in Preterm Infants: A Pooled Analysis of Four Phase Three Studies.
Pediatr Infect Dis J
; 42(11): 1021-1028, 2023 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37566897
18.
A Phase III, multicenter, randomized, double-blind, active comparator-controlled study to evaluate the safety, tolerability, and immunogenicity of V114 compared with PCV13 in healthy infants (PNEU-PED-EU-1).
Vaccine
; 41(21): 3387-3398, 2023 05 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37105892
19.
Safety and Tolerability of V114 Pneumococcal Vaccine in Infants: A Phase 3 Study.
Pediatrics
; 152(1)2023 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37309607
20.
A phase III, multicenter, randomized, double-blind, active comparator-controlled study to evaluate the safety, tolerability, and immunogenicity of catch-up vaccination regimens of V114, a 15-valent pneumococcal conjugate vaccine, in healthy infants, children, and adolescents (PNEU-PLAN).
Vaccine
; 40(44): 6315-6325, 2022 10 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-36150974